Follow-up in patients with localised primary cutaneous melanoma.
about
Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterialsFollow-up in melanoma patientsA Global Review of Melanoma Follow-up GuidelinesLong-term follow-up for melanoma patients: is there any evidence of a benefit?The European approach to in-transit melanoma lesions.Distant melanoma causing small bowel obstruction.Patient satisfaction with GP-led melanoma follow-up: a randomised controlled trial.Detection of melanoma nodal metastases; differences in detection between elderly and younger patients do not affect survival.Surviving cutaneous melanoma: a clinical review of follow-up practices, surveillance, and management of recurrence.Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic reviewContemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis.Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians' perspectives and models of care.Increased risk of second primary cancers after a diagnosis of melanomaDepression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.Review of diagnostic imaging modalities for the surveillance of melanoma patientsUse of S-100B to evaluate therapy effects during bevacizumab induction treatment in AJCC stage III melanoma.Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomasIt is never too late: ultra-late recurrence of melanoma with distant metastases.Loss of MiR-664 Expression Enhances Cutaneous Malignant Melanoma Proliferation by Upregulating PLP2Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis.Therapeutic lymph node dissection in melanoma: different prognosis for different macrometastasis sites?Brazilian guidelines for diagnosis, treatment and follow-up of primary cutaneous melanoma - Part IIThe MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 YearFollow-up of cancer in primary care versus secondary care: systematic review.Patients' and healthcare professionals' views of cancer follow-up: systematic review.A systematic review of health-related quality of life in cutaneous melanoma.S-100B concentrations predict disease-free survival in stage III melanoma patients.The role of ultrasound and ultrasound-guided fine needle aspiration biopsy of lymph nodes in patients with skin tumours.Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: a systematic review of the literature.Intensity of follow-up after melanoma surgery.Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review.Isolated limb perfusion for in-transit melanoma metastases: melphalan or TNF-melphalan perfusion?Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis.Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.Temporal trends in healthcare utilization following primary melanoma diagnosis among Medicare beneficiaries.How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center?Development of a targeted risk-group model for skin cancer screening based on more than 100,000 total skin examinations.Psychoeducational intervention for people at high risk of developing another melanoma: a pilot randomised controlled trial.Is GP-led follow-up feasible?Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.
P2860
Q26860518-0468C97B-C82E-4DAE-BC14-7A3CB554AB3DQ26999904-8E93F9E2-F397-4229-9DD4-D4F5FCC7F1C9Q27004541-4F022DE3-4C3E-4874-B2BB-A957F2EAAAD1Q27007043-71B9E747-1CF5-4CD8-A592-3941DA5E2B4FQ33327121-0424D501-BA6A-4F5D-828D-82A8B842EAF8Q33591004-C109ACEE-AE48-4F4B-80B0-DC95F3FD7A6BQ33847817-8CBA044B-6895-4F74-9AAC-510845045C51Q34180205-51EB6B74-6E1C-4A31-B5C0-E41AEF5E1459Q34235463-7B309F10-CBD9-45EA-AAD5-BD6B289DFA9BQ34390108-3A3F3F0F-66A7-484B-B7B1-75C8D0400D89Q34498776-460792E2-48D7-4750-85B4-0B2A472FC013Q34518455-2BCB59E0-7952-4046-B57B-038DAC6AB63FQ34793496-C51C5AA2-5E0D-4DB5-B1F2-14B26B21DA9FQ35007095-1A8E6E16-FFA2-405E-ABB1-D47B712B8F98Q35184338-D2CEB360-D44D-4325-B81F-C147503632CEQ35691033-B31FC0E6-23B0-49E0-856E-169835B79950Q35845352-4F57BB4B-E8E8-48C3-9BB4-23302F0CF966Q35863439-07DA1AE9-85F2-4D79-8FE9-26E949DBF276Q36194074-7C4B8967-B05C-4DD6-9F02-B1B99B000BABQ36277934-7344F1F7-8718-4FBB-B1EE-C05688A446B8Q36339446-02A7BD3F-E3B2-446C-BD7A-92F71077FBFCQ36663207-02F4A294-E802-4DAC-8464-4A8E16D6E3C4Q37150453-7BF8877B-9537-4745-91D6-FB5FA21A9ACAQ37241794-9F0F8902-A902-4AF2-BFF9-06B6426C7108Q37241798-3C100BE4-F70C-4F8D-9855-F4F5161615D8Q37266674-FF1923E6-FB4E-4542-927B-8BBD61380EE8Q37425922-B4068F09-0F5F-4E3D-945C-BF314FA2C0FBQ37537879-55F09656-6A5C-40B5-A02E-6C7E7B360C0BQ37995135-5BFD632E-3EF1-47A6-8B2E-1858AFDD9728Q38151491-45CAE90D-3AAC-49E7-997C-CA77E62092CDQ38151728-782D8E8F-A63B-4D85-AC19-962C2669E92CQ38176854-DF7D7C34-9F1B-40EC-A2B2-9B410F0B34F6Q38285886-43D2B520-B811-4B29-8054-3FA56A1A7FE6Q38431792-368AB5F7-8730-420F-9E59-1FD80E043284Q38859865-19F0CA72-393B-4ADF-BCE1-AC3D2A7B95F0Q40950797-76424744-F4B5-497B-8E54-3DF6183520CDQ42484750-558A959A-2E2A-4F41-920F-D7CF6610B06EQ42650239-09090331-F637-4441-89B4-07805E8B3027Q42783698-49EEC23C-05F4-4922-95C9-2C95DED2B3E4Q43705084-DF9267C1-86F3-45CA-BE5E-8FBAD9B2D0A7
P2860
Follow-up in patients with localised primary cutaneous melanoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Follow-up in patients with localised primary cutaneous melanoma.
@ast
Follow-up in patients with localised primary cutaneous melanoma.
@en
type
label
Follow-up in patients with localised primary cutaneous melanoma.
@ast
Follow-up in patients with localised primary cutaneous melanoma.
@en
prefLabel
Follow-up in patients with localised primary cutaneous melanoma.
@ast
Follow-up in patients with localised primary cutaneous melanoma.
@en
P2093
P1433
P1476
Follow-up in patients with localised primary cutaneous melanoma.
@en
P2093
Anne Brecht Francken
Esther Bastiaannet
Harald J Hoekstra
P304
P356
10.1016/S1470-2045(05)70283-7
P577
2005-08-01T00:00:00Z